|
From The Editor
|
 More than 11,000 professionals from the pharmaceutical and biopharmaceutical manufacturing, processing, and services industries gathered at this year’s INTERPHEX conference and exhibition at New York City’s Javits Center. With so much expertise in one place, it gave me the perfect opportunity to dig deeper into the issues and innovations that are top of mind in the market today. With camcorder in tow, I navigated my way around the exhibition floor to capture the experts’ takes on today’s manufacturing challenges, get a first-hand look at the latest technologies, and uncover how those technologies are promoting progress within the pharmaceutical manufacturing industry. Check out our INTERPHEX 2012 video gallery to see who expressed their views on single-use technologies, solid-dose manufacturing, continuous processing, and more. |
|
|
|
Featured Articles
|
|
The Quest To Reinfuse Venture Capital Into Biotech Funding
By Sara Gambrill, contributing editor
Why Big Pharma needs to take a new approach to investing in early-stage biotech companies for the health of their pipelines, the industry, and ultimately, patients.
|
|
|
Vial Closures And Stoppering Force In Pilot Freeze-Dryers
By Leslie Mather, SP Scientific
On occasion, we are challenged with regard to equipment being able to properly seal a customer’s selection of container-closure system, typically a glass vial and rubber stopper that is pressed down into the vial during a stoppering step at the end of freeze drying. This became a more frequent problem as dosages and containers decreased in size, because this configuration typically requires more force per square inch to create proper stopper seating in the vial.
|
|
|
|
|
|
|
|
|
|
|
Bulletin Board
|
 |
|
Bio-G Webinar: Capacity Planning In Biomanufacturing — Effectively Managing Uncertainty |
Americas: May 30, 2012 | 1:00 PM PDT, 4:00 PM EDT
Europe: May 30, 2012 | 3:00 PM GMT, 4:00 PM CET
Capacity planning for new molecules in biotech is fraught with uncertainty. Supply constraints, unknown titers, number of patients and dosing, as well as the probability of technical success (PTS), make capacity planning difficult. This webinar will outline a number of approaches to understanding and managing the uncertainty associated with capacity planning. Learn more. |
|
|
|
|
|
